705 research outputs found
Optical phase coherent timing of the Crab nebula pulsar with Iqueye at the ESO New Technology Telescope
The Crab nebula pulsar was observed in 2009 January and December with a novel
very fast optical photon counter, Iqueye, mounted at the ESO 3.5 m New
Technology Telescope. Thanks to the exquisite quality of the Iqueye data, we
computed accurate phase coherent timing solutions for the two observing runs
and over the entire year 2009. Our statistical uncertainty on the determination
of the phase of the main pulse and the rotational period of the pulsar for
short (a few days) time intervals are s and ~0.5 ps,
respectively. Comparison with the Jodrell Bank radio ephemerides shows that the
optical pulse leads the radio one by ~240 s in January and ~160 s in
December, in agreement with a number of other measurements performed after
1996. A third-order polynomial fit adequately describes the spin-down for the
2009 January plus December optical observations. The phase noise is consistent
with being Gaussian distributed with a dispersion of s in most observations, in agreement with theoretical expectations for
photon noise-induced phase variability.Comment: 10 pages, 5 figures. Accepted for publication in Monthly Notices of
the Royal Astronomical Societ
Three-dimensional numerical modeling of tsunami-related internal gravity waves in the Hawaiian atmosphere
The tremendous tsunami following the 2011 Tohoku Earthquake produced internal gravity waves (IGWs) in the neutral atmosphere and large disturbances in the. overlying ionospheric plasma while propagating through the Pacific ocean. To corroborate the tsunamigenic hypothesis of these perturbations, we use a 3D numerical modeling of the ocean-atmosphere coupling, to reproduce the tsunami signature observed in the airglow by the imager located in Hawaii and clearly showing the shape of the modeled IGW. The agreement between data and synthetics not only supports the interpretation of the tsunami-related-IGW behavior, but strongly shows that atmospheric and ionospheric remote sensing can provide new tools for oceanic monitoring and tsunami detection
Collimator design for a clinical brain SPECT/MRI insert
This project's goal is to design a SPECT insert for a clinical MRI system for simultaneous brain SPECT/MR imaging. We assume the stationary SPECT insert will consist of two rings of ∼5x5-cm SiPM-based detectors insensitive to magnetic fields, with 0.8-mm intrinsic resolution. The maximum diameter is 44.5 cm, the minimum diameter is 33 cm to accommodate the patient and MRI receive/transmit coil, and the FOV has a 20 cm diameter.
We have compared eight collimator designs: single-, 2x2-, 3x3- and 5+2½- pinhole, and single-, 2-, 3- and 1+2½-slit slit-slat, where ½-pinholes/slits are shared between two detectors. Analytical geometric efficiency was calculated for an activity distribution corresponding to a human brain and a target resolution of 10 mm FWHM at the centre of the FOV. Noise-free data were simulated with and without depth-of-interaction (DOI) information, and reconstructed for uniform, Defrise, Derenzo, and Zubal brain phantoms. For DOI it is assumed that the crystal's first and second half can be differentiated.
Comparing the multi-pinhole and multi-slit slit-slat collimators, the former gives better reconstructed uniformity and trans-axial resolution, while the latter gives better axial resolution. Although the 2x2-pinhole and 2-slit designs give the highest sensitivities, they result in a sub-optimal utilization of the detector FOV. The best options are therefore the 5+2½-pinhole and the 1+2½-slit systems, with sensitivities of 4.9*10–4 and 4.0*10–4, respectively. The brain phantom reconstructions with multi-pinhole collimator are superior as compared to slit-slat, especially in terms of symmetry and realistic activity distribution. DOI information reduces artefacts and improves uniformity in geometric phantoms, although the difference is small for the brain phantom. These results favour a multi-pinhole configuration
Aqueye optical observations of the Crab Nebula pulsar
We observed the Crab pulsar in October 2008 at the Copernico Telescope in
Asiago - Cima Ekar with the optical photon counter Aqueye (the Asiago Quantum
Eye) which has the best temporal resolution and accuracy ever achieved in the
optical domain (hundreds of picoseconds). Our goal was to perform a detailed
analysis of the optical period and phase drift of the main peak of the Crab
pulsar and compare it with the Jodrell Bank ephemerides. We determined the
position of the main peak using the steepest zero of the cross-correlation
function between the pulsar signal and an accurate optical template. The pulsar
rotational period and period derivative have been measured with great accuracy
using observations covering only a 2 day time interval. The error on the period
is 1.7 ps, limited only by the statistical uncertainty. Both the rotational
frequency and its first derivative are in agreement with those from the Jodrell
Bank radio ephemerides archive. We also found evidence of the optical peak
leading the radio one by ~230 microseconds. The distribution of phase-residuals
of the whole dataset is slightly wider than that of a synthetic signal
generated as a sequence of pulses distributed in time with the probability
proportional to the pulse shape, such as the average count rate and background
level are those of the Crab pulsar observed with Aqueye. The counting
statistics and quality of the data allowed us to determine the pulsar period
and period derivative with great accuracy in 2 days only. The time of arrival
of the optical peak of the Crab pulsar leads the radio one in agreement with
what recently reported in the literature. The distribution of the phase
residuals can be approximated with a Gaussian and is consistent with being
completely caused by photon noise (for the best data sets).Comment: 7 pages, 7 figures. Accepted for publication in Astronomy and
Astrophysic
eHealth literacy in prostate cancer: A systematic review.
OBJECTIVE: This systematic review (PROSPERO ID: CRD42022226375) aimed to identify the eHealth literacy of men with prostate cancer, and their caregivers. METHODS: 8 databases (MEDLINE, SCOPUS, EMBASE, Web Of Science, PsycINFO, ERIC, CINAHL, Cochrane CENTRAL) and grey literature sources (e.g. Google Scholar) were searched from inception to December 2023. Articles were included if assessing eHealth/digital literacy of men with prostate cancer, or their carers', and health outcome associations. Formats such as case reports, and review papers were excluded. Records and full texts underwent independent screening and data extraction. Author disagreements were resolved by discussion. The Mixed Methods Appraisal Tool (MMAT) was used to appraise included literature, with narrative synthesis of results. RESULTS: 21,581 records were retrieved, with 7 articles satisfying inclusion criteria. A heterogenous field was characterised with lack of modern eHealth literacy measurement tools identified. Results suggest novice eHealth literacy using web 1.0 technologies. Non-validated measures of literacy demonstrate mixed results, while health outcome effects limited in scope and reliability. CONCLUSION: Prostate cancer survivors' eHealth literacy levels is likely novice, and requires further investigation. PRACTICE IMPLICATIONS: Digital technologies/resources implemented as part of patient communication practices should be vetted for quality, and tailored to patients' eHealth literacy abilities and/or needs
Crizotinib plus radiotherapy in brain oligoprogressive NSCLC ROS1 rearranged and PD-L1 strong
ROS1+ patients represent a unique molecular subset of non-small cell lung cancer (NSCLC). Early phase clinical trials have shown a high response rate to crizotinib in these patients. We describe a case of an 18 years old woman, never smoker, with NSCLC ROS1+ and miliary brain metastases treated with crizotinib and radiotherapy. From October 2014 to June 2015 the Patient was treated with crizotinib. The first intracranial time to progression (IT-TTP) occurred after 7 months; the patient underwent stereotactic radiosurgery (SRS) and continued TKI treatment. The second IT-TTP appeared after 16 months. A continued response in the chest was observed for all the 23 months of crizotinib treatment. At the progression, we assessed programmed death ligand 1 (PD-L1) expression by immunohistochemistry, that resulted highly expressed. Our report indicates that the integration of crizotinib with local treatments should be considered in ROS1 NSCLC patients experiencing oligometastatic progression. Moreover, this case is an example of PD-L1 strong in oncogene addicted patients
Low levels of urinary psa better identify prostate cancer patients
SIMPLE SUMMARY: Elevated PSA levels in blood tests are the gold standard for early prostate cancer detection, but its lack of specificity limits its clinical use as a mass screening test. The paradox is that it has long been known that advanced prostate cancers can lose PSA expression. We have observed that in the presence of tumors, the prostate produces and secretes less PSA than in healthy or benign conditions. Therefore, the PSA evaluation in urine provided more accurate information on the presence of prostate tumors than the blood test, representing a new method for the screening of prostate cancer. ABSTRACT: Serum prostatic specific antigen (PSA) has proven to have limited accuracy in early diagnosis and in making clinical decisions about different therapies for prostate cancer (PCa). This is partially due to the fact that an increase in PSA in the blood is due to the compromised architecture of the prostate, which is only observed in advanced cancer. On the contrary, PSA observed in the urine (uPSA) reflects the quantity produced by the prostate, and therefore can give more information about the presence of disease. We enrolled 574 men scheduled for prostate biopsy at the urology clinic, and levels of uPSA were evaluated. uPSA levels resulted lower among subjects with PCa when compared to patients with negative biopsies. An indirect correlation was observed between uPSA amount and the stage of disease. Loss of expression of PSA appears as a characteristic of prostate cancer development and its evaluation in urine represents an interesting approach for the early detection of the disease and the stratification of patients
Unexpected long survival of brain oligometastatic non-small cell lung cancer (NSCLC) treated with multimodal treatment: A single-center experience and review of the literature
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related death worldwide. Fifty percent of the cases are metastatic at diagnosis and about 20% develop brain metastasis. The brain involvement represents a negative prognostic factor. However, some patients could benefit from locoregional treatments of metastatic foci and experience an unexpected long survival or healing. In the previous years some classifications were proposed to identify patients' prognostic category, according to stage of the primary tumor, the timing of metastases occurrence (synchronous or metachronous) and the number of metastatic sites. Several data show a benefit in patients receiving resection of both the primary tumor and brain metastases. Whole brain radiotherapy (WBRT) and stereotactic radiosurgery (SRS) are the selected options in most cases. Overall, literature data showed highly variable outcome, with an overall survival (OS) ranging from 5.9 to 68 months. No data from randomized and homogeneous trials are currently available. Therefore, a growing interest in this field is observed. Different trials investigating the effectiveness of local treatments and studies analyzing biological mechanisms are ongoing. In this report we analyze literature data and we explore the current field of study. Furthermore, we show a single institutional experience of multimodal management of stage IV NSCLC with brain metastases, experiencing an unexpected long survival. We conclude that a better knowledge of this subpopulation of patients and new studies in this field can lead to distinguish the patients who can benefit from local treatment from those with poor prognosis
- …